. Author manuscript; available in PMC: 2009 Oct 23.

Published in final edited form as: Cancer Epidemiol Biomarkers Prev. 2008 Aug;17(8):2012–2018. doi: 10.1158/1055-9965.EPI-08-0032

Table 4.

Joint association of serum p’p-DDE concentration and androgen receptor genotype with TGCC risk.

	Adjusted odds ratio^* (95% confidence interval) (No. cases/No. controls)
	p’p-DDE concentration (pg/g)
AR genotype	≤1,101	>1101–2473	>2,473	P_interaction
CAG repeat length
≤23	1.0 (Referent) (87/189)	1.3 (0.8–2.0) (69/138)	0.6 (0.3–1.2) (15/67)
>23	0.9 (0.5–1.4) (35/94)	0.9 (0.5–1.6) (24/67)	0.6 (0.2–2.0) (5/21)	0.8
GGC repeat length
≤17	1.0 (Referent) (74/177)	0.9 (0.6–1.6) (47/125)	0.5 (0.2–1.2) (12/57)
>17	0.9 (0.6–1.4) (48/106)	1.4 (0.9–2.4) (46/80)	0.7 (0.3–1.7) (8/31)	0.3

adjusted for age, race, change in body mass index between reference date and blood draw, assay run number and serum lipids